This inventor holds 0 USPTO granted patents, plus 3 CIPO patents.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Title: Donna M. Dunleavy: Innovator in Antibody Formulation
Introduction
Donna M. Dunleavy is a notable inventor in the field of pharmaceutical formulations, particularly focusing on antigen binding proteins such as monoclonal antibodies. Her work contributes significantly to advancements in medical treatments and therapies.
Latest Patents
Donna M. Dunleavy holds a patent for an innovative Antibody Formulation. This invention relates to pharmaceutical formulations that include a pharmaceutically active antigen binding protein, along with a buffering agent and a tonicity agent. Despite having 0 patents, her contributions to the field are noteworthy.
Career Highlights
Donna is currently associated with GlaxoSmithKline Intellectual Property Management Limited, where she applies her expertise in developing pharmaceutical formulations. Her role involves significant research and development efforts aimed at improving therapeutic options.
Collaborations
Throughout her career, Donna has collaborated with talented professionals, including Angela Blake-Haskins and Tristan Marshall. These collaborations enhance the innovative potential of her work and contribute to the success of their projects.
Conclusion
Donna M. Dunleavy is a dedicated inventor whose work in antibody formulation plays a crucial role in the pharmaceutical industry. Her contributions, although currently limited in patent count, reflect her commitment to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile